Today (16 November), the Moderna pharmaceutical company published phase 3 results for its mRNA vaccine indicating an estimated vaccine efficacy of 94.5%. Moderna’s vaccine may be...
Russia’s Sputnik V vaccine is 92% effective at protecting people from COVID-19 according to interim trial results, the country’s sovereign wealth fund said on Wednesday (11...
Vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy...
Italy’s main medicines regulator gave the go-ahead on Tuesday (27 October) for human clinical trials on raloxifene, a generic osteoporosis drug that researchers hope may also...
Germany’s health minister expects a COVID-19 vaccine to be available early next year and believes a large proportion of Germans who want the shot could be...
The European Centre for Disease Prevention and Control (ECDC) published its updated risk assessment regarding the COVID-19 pandemic, alongside a set of guidelines for non-pharmaceutical interventions (such as hand...
The European Commission has today concluded exploratory talks with BioNTech-Pfizer to purchase a potential vaccine against COVID-19. BioNTech-Pfizer is the sixth company with which the Commission...